Long-term outcomes of distant metastasis from differentiated thyroid carcinoma

Clinical Endocrinology

Volumn 76, Issue 3, 2012, Pages 439-447

  Huang, I Chin ^a   Chou, Feng Fu ^a   Liu, Rue Tsuan ^a   Tung, Shih Chen ^a   Chen, Jung Fu ^a   Kuo, Ming Chun ^a   Hsieh, Ching Jung ^a   Wang, Pei Wen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BONE METASTASIS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CERVICAL LYMPH NODE; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL;

ADULT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863013702     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04231.x     Document Type: Article

References (33)

1. Hundahl, S.A., Fleming, I.D., Fremgen, A.M., et al. (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer, 83, 2638-2648. (Pubitemid 29019586)
2. Brown, A.P., Greening, W.P., McCready, V.R., et al. (1984) Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. British Journal of Radiology, 57, 323-327. (Pubitemid 14165273)
3. Schlumberger, M., Tubiana, M., De Vathaire, F., et al. (1986) Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 63, 960-967. (Pubitemid 16004302)
4. Ruegemer, J.J., Hay, I.D., Bergstralh, E.J., et al. (1988) Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. Journal of Clinical Endocrinology and Metabolism, 67, 501-508.
5. Schlumberger, M., Challeton, C., De Vathaire, F., et al. (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. Journal of Nuclear Medicine, 37, 598-605. (Pubitemid 126618447)
6. Mihailovic, J., Stefanovic, L., Malesevic, M., et al. (2009) The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases. Thyroid, 19, 227-232.
7. Pacini, F., Cetani, F., Miccoli, P., et al. (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World Journal of Surgery, 18, 600-604. (Pubitemid 24273863)
8. Lee, J., &, Soh, E.Y., (2010) Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Annals of Surgery, 251, 114-119.
9. Durante, C., Haddy, N., Baudin, E., et al. (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. Journal of Clinical Endocrinology and Metabolism, 91, 2892-2899. (Pubitemid 44271732)
10. Shoup, M., Stojadinovic, A., Nissan, A., et al. (2003) Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. Journal of the American College of Surgeons, 197, 191-197. (Pubitemid 36927381)
11. Cooper, D.S., Doherty, G.M., Haugen, B.R., et al. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214.
12. Sywak, M., Cornford, L., Roach, P., et al. (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery, 140, 1000-1005. discussion 1005-1007.
13. Hughes, D.T., White, M.L., Miller, B.S., et al. (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery, 148, 1100-1106. discussion 1006-1107.
14. Maxon, H.R. 3rd, &, Smith, H.S., (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinology and Metabolism Clinics of North America, 19, 685-718. (Pubitemid 20282663)
15. Rubino, C., de Vathaire, F., Dottorini, M.E., et al. (2003) Second primary malignancies in thyroid cancer patients. British Journal of Cancer, 89, 1638-1644. (Pubitemid 37464133)
16. Kloos, R.T., Duvuuri, V., Jhiang, S.M., et al. (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 87, 5817-5820. (Pubitemid 36034394)
17. Mandel, S.J., &, Mandel, L., (2003) Radioactive iodine and the salivary glands. Thyroid, 13, 265-271. (Pubitemid 36459308)
18. Walter, M.A., Turtschi, C.P., Schindler, C., et al. (2007) The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study. Journal of Nuclear Medicine, 48, 1620-1625. (Pubitemid 47572709)
19. AJCC (American Joint Committee on Cancer). (2010) Thyroid. In:, S.B. Edge, D.R. Byrd, &, C.C. Compton, et al., eds. Cancer Staging Manual, 7th edn. Springer-Verlag, New York, pp 87-96.
20. Brierley, J., Tsang, R., Panzarella, T., et al. (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clinical Endocrinology, 63, 418-427. (Pubitemid 41442336)
21. Robbins, R.J., Srivastava, S., Shaha, A., et al. (2004) Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 89, 6010-6016. (Pubitemid 39628408)
22. Bachelot, A., Cailleux, A.F., Klain, M., et al. (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid, 12, 707-711. (Pubitemid 34913243)
23. Francis, Z., &, Schlumberger, M., (2008) Serum thyroglobulin determination in thyroid cancer patients. Best Practice & Research. Clinical Endocrinology & Metabolism, 22, 1039-1046.
24. Spencer, C.A., &, Wang, C.C., (1995) Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinology and Metabolism Clinics of North America 24, 841-863.
25. Brendel, A.J., Lambert, B., Guyot, M., et al. (1990) Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. European Journal of Nuclear Medicine 16, 35-38. (Pubitemid 20085684)
26. Podnos, Y.D., Smith, D., Wagman, L.D., et al. (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. American Surgeon 71, 731-734.
27. Zaydfudim, V., Feurer, I.D., Griffin, M.R., et al. (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144, 1070-1077. discussion 1077-1078.
28. Elisei, R., Molinaro, E., Agate, L., et al. (2010) Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. Journal of Clinical Endocrinology and Metabolism 95, 1516-1527.
29. Hartl, D.M., &, Travagli, J.P., (2009) The updated American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: a surgical perspective. Thyroid 19, 1149-1151.
30. Bonnet, S., Hartl, D., Leboulleux, S., et al. (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. Journal of Clinical Endocrinology and Metabolism 94, 1162-1167.
31. Sandeep, T.C., Strachan, M.W., Reynolds, R.M., et al. (2006) Second primary cancers in thyroid cancer patients: a multinational record linkage study. Journal of Clinical Endocrinology and Metabolism 91, 1819-1825.
32. Subramanian, S., Goldstein, D.P., Parlea, L., et al. (2007) Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid 17, 1277-1288.
33. Brown, A.P., Chen, J., Hitchcock, Y.J., et al. (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 93, 504-515. (Pubitemid 351240823)